A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Henan Cancer Hospital
Calibr, a division of Scripps Research
University of Chicago
BeOne Medicines
Eli Lilly and Company
BeOne Medicines
Eli Lilly and Company
Prelude Therapeutics
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
BeOne Medicines
University of Arizona
Boryung Pharmaceutical Co., Ltd
Universität des Saarlandes
Incyte Corporation
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Ohio State University Comprehensive Cancer Center
University of California, Davis
University of Washington
Hutchmed
Fred Hutchinson Cancer Center
Oncternal Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
International Extranodal Lymphoma Study Group (IELSG)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
AstraZeneca
Stanford University
Xencor, Inc.
BeiGene
BeiGene
Stanford University
University of Nebraska
University of Rochester
Calibr, a division of Scripps Research
City of Hope Medical Center
Shanghai YingLi Pharmaceutical Co. Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
City of Hope Medical Center
Celldex Therapeutics
Ipsen
University of Colorado, Denver